Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

NVCR

NovoCure Ltd

Surgical & Medical Instruments & Apparatus · SIC 3841CIK 1645113Held by 2 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$655.0M
Net Income FY2025
$(136.0M)
EPS (Basic, as reported)
$-1.22
Net Margin FY2025
-20.8%
ROE FY2025
-40.0%
Total Equity
$340.0M
Shares Out
117M
Business description

NovoCure Ltd — Surgical & Medical Instruments & Apparatus. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2013–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 83 → 655 +25.8% CAGR
Revenue83177248351494535538509605655
Cost of revenue(40)(56)(80)(89)(107)(115)(115)(128)(137)(167)
Gross profit37121168263388420423381468488
Research & development(41)(38)(51)(79)(132)(201)(206)(223)(210)(225)
Selling & marketing(59)(64)(78)(97)(118)(137)(174)(227)(239)(240)
General & administrative(51)(59)(73)(88)(107)(126)(133)(164)(190)(178)
Total operating expenses(152)(161)(202)(264)(357)(464)(512)(614)(639)(642)
Operating income(115)(39)(34)(1)30(44)(90)(233)(170)(154)
Interest expense(7)(12)(17)(15)(18)(9)(8)(5)(12)(22)
Interest & investment income11342111202313
Pre-tax income(121)(48)(46)(9)18(52)(82)(192)(131)(136)
Income tax expense(10)(13)(18)(2)(2)(6)(11)(15)(37)0
Net income(132)(62)(64)(7)20(58)(93)(207)(169)(136)
EPS — basic——($0.69)($0.07)$0.20($0.56)($0.88)($1.95)($1.56)($1.22)
EPS — diluted——($0.69)($0.07)$0.18($0.56)($0.88)($1.95)($1.56)($1.22)
Shares outstanding — basic (M)——9297101103105106108111
Shares outstanding — diluted (M)——9297109103105106108111

Showing the latest 10 of 13 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.